Active site binding modes of curcumin in HIV-1 protease and integrase

被引:100
|
作者
Vajragupta, O
Boonchoong, P
Morris, GM
Olson, AJ
机构
[1] Mahidol Univ, Fac Pharm, Dept Pharmaceut Chem, Bangkok 10400, Thailand
[2] Ubon Rajathanee Univ, Fac Pharmaceut Sci, Div Pharmaceut Chem & Technol, Ubon Ratchathani 34190, Thailand
[3] Scripps Res Inst, Dept Mol Biol, Mol Graph Lab, La Jolla, CA 92037 USA
关键词
curcumin; HIV-1; HIV integrase; HIV protease; 5-CITEP; docking;
D O I
10.1016/j.bmcl.2005.05.032
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Structure models for the interaction of curcumin with HIV-1 integrase (IN) and protease (PR) were investigated using computational docking. Curcumin was found to bind preferentially in similar ways to the active sites of both IN and PR. For IN, the binding site is formed by residues Asp64, His67, Thr66, Glu92, Thr93, Asp116, Ser119, Asn120, and Lys159. Docked curcumin contacts the catalytic residues adjacent to Asp116 and Asp64, and near the divalent metal (Mg2+). In the PR docking, the curcumin structure fitted well to the active site, interacting with residues Asp25, Asp29, Asp30, Gly27', Asp29', and Asp30'. The results suggest that o-hydroxyl and/or keto-enol structures are important for both IN and PR inhibitory actions. The symmetrical structure of curcumin seems to play an important role for binding to the PR protein, whereas the keto-enol and only one side of the terminal o-hydroxyl showed tight binding to the IN active site. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3364 / 3368
页数:5
相关论文
共 50 条
  • [1] Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase
    Gupta, Pawan
    Kumar, Rajender
    Garg, Prabha
    Singh, Inder Pal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (15) : 4427 - 4431
  • [2] Active site binding modes of the β-diketoacids:: a multi-active site approach in HIV-1 integrase inhibitor design
    Dayam, R
    Neamati, N
    BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (24) : 6371 - 6381
  • [3] The active site of HIV-1 protease
    Mager, PP
    MEDICINAL RESEARCH REVIEWS, 2001, 21 (04) : 348 - 353
  • [4] Binding modes of two highly potent and non-toxic inhibitors of HIV-1 integrase
    Zhu, HM
    Chen, WZ
    Wang, CX
    PROCEEDINGS OF THE 26TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY, VOLS 1-7, 2004, 26 : 3003 - 3006
  • [5] Investigation of the protonated state of HIV-1 protease active site
    Nam, KY
    Chang, BH
    Han, CK
    Ahn, SG
    No, KT
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2003, 24 (06) : 817 - 823
  • [6] Identification of the LEDGF/p75 binding site in HIV-1 integrase
    Busschots, Katrien
    Voet, Arnout
    De Maeyer, Marc
    Rain, Jean-Christophe
    Emiliani, Stephane
    Benarous, Richard
    Desender, Linda
    Debyser, Zeger
    Christ, Frauke
    JOURNAL OF MOLECULAR BIOLOGY, 2007, 365 (05) : 1480 - 1492
  • [7] HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta prostrata
    Tewtrakul, Supinya
    Subhadhirasakul, Sanan
    Cheenpracha, Sarot
    Karalai, Chatchanok
    PHYTOTHERAPY RESEARCH, 2007, 21 (11) : 1092 - 1095
  • [8] Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding
    Lins, RD
    Straatsma, TP
    Briggs, JM
    BIOPOLYMERS, 2000, 53 (04) : 308 - 315
  • [9] Studies on the binding modes of HIV-1 integrase with viral DNA via molecular docking method
    Hu Jian-Ping
    Ke Guo-Tao
    Chang Shan
    Chen Wei-Zu
    Wang Cun-Xin
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2008, 29 (07): : 1432 - 1437
  • [10] Defining the DNA Substrate Binding Sites on HIV-1 Integrase
    Dolan, James
    Chen, Aiping
    Weber, Irene T.
    Harrison, Robert W.
    Leis, Jonathan
    JOURNAL OF MOLECULAR BIOLOGY, 2009, 385 (02) : 568 - 579